Deborah Charfoos
Obstetrics & Gynecology · West Bloomfield, MINPI 1154316776
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 32.1% of the total. Reporting peaked in 2019 at $773 and has fallen 68.8% since, to $241 in 2023.
Across 121 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$745
- Amgen$238
- Ascend Therapeutics US, LLC$134
- Pfizer$122
- AstraZeneca$112
- Hologic Sales And Service, LLC$90
- plus $880 from 20 others
What the payments were for
- Food & beverage$2,24797%
- Education$743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $745 |
| Amgen | 10 | $238 |
| Ascend Therapeutics US, LLC | 7 | $134 |
| Pfizer | 7 | $122 |
| AstraZeneca | 1 | $112 |
| Hologic Sales And Service, LLC | 4 | $90 |
| Organon | 4 | $84 |
| Daiichi Sankyo Inc. | 5 | $84 |
| Mayne Pharma Commercial LLC | 4 | $84 |
| Gynesonics, Inc. | 1 | $72 |
| Therapeuticsmd, Inc. | 5 | $63 |
| AMAG Pharmaceuticals, Inc. | 4 | $57 |
| Astellas Pharma US Inc | 3 | $55 |
| Coopersurgical, Inc. | 3 | $54 |
| Avion Pharmaceuticals | 4 | $53 |
| Aspira Women's Health Inc | 1 | $50 |
| Myovant Sciences Inc. | 2 | $43 |
| Evofem Biosciences, Inc. | 2 | $42 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Exeltis, USA Inc. | 2 | $24 |
| Bayer | 1 | $20 |
| Merck | 1 | $17 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
| BD | 1 | $12 |
| Acessa Health Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$112
How this compares
$2,321 in reported general payments places this provider in the 80th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,294 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in West Bloomfield
- Jay FisherWest Bloomfield$136K
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Barbara DepreeZeeland$118K
- Rabbie HannaDetroit$105K
- Gregory GresselGrand Rapids$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.